Characterization of protein therapeutics using mass spectrometry /
Protein therapeutics' high efficacy, safety, and ability to treat life-threatening diseases such as cancer, inflammation and genetic disorders have revolutionized modern medicine. In 2012, 200 companies competed in this $90 billion year industry. In Characterization of Protein Therapeutics us...
Saved in:
| Corporate Author: | |
|---|---|
| Format: | eBook |
| Language: | English |
| Published: |
Boston, MA
Springer US Imprint: Springer,
2013.
|
| Subjects: | |
| Online Access: | Click here to view the full text content |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Table of Contents:
- Characterization of Protein Therapeutics by Mass Spectrometry: Recent Developments and Future Directions
- The Use of Mass Spectrometry to Characterize the Metabolism of Peptide Therapeutics
- Quantitative Analysis of Biologics Using Mass Spectrometry
- Maximizing Structural Information from Whole Protein Tandem Mass Spectrometry
- Disulfide Linkages of an Albumin Fusion Protein
- Detailed Structural Characterization of Monoclonal Antibodies
- Application of Protein Mass Spectrometry in Impurity and Degradant Characterization
- Mass Spectrometry Methods to Analyze Higher Order Structure of Protein Therapeutics by Chemical Footprinting
- Aglycosylations Alters Protein Conformation in Antibodies Engineered with Specific Effector Functions Using HDX-MS
- Characterizing Biotherapeutic Protein 3D Structures by Electrospray Ion-Mobility Mass Spectrometry
- Oxford University, Characterization of Assemblies of Proteins by Mass Spectrometry.